Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alagille Syndrome (ALGS)”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Study completedNCT02117713
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 34
Not applicableStudy completedNCT02922751
What this trial is testing

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

Who this might be right for
Biliary AtresiaAlagille SyndromeAlpha1 Anti-Trypsin Deficiency+3 more
Arbor Research Collaborative for Health 552
Not applicableUnknownNCT05846854
What this trial is testing

Decreasing Hemorrhage Risk in Children With Alagille Syndrome

Who this might be right for
Alagille SyndromePulmonary Artery StenosesAcquired Von Willebrand Disease
Stanford University 40
Not applicableLooking for participantsNCT06767605
What this trial is testing

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Who this might be right for
Hepatitis Autoimmune DiseasePrimary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)+1 more
Asociación Española para el Estudio del Hígado 5,000
Not applicableStudy completedNCT01515631
What this trial is testing

Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review

Who this might be right for
Alagille Syndrome
Stanford University 25
Not applicableStudy completedNCT00001642
What this trial is testing

Positional Cloning of the Gene(s) Responsible for Alagille Syndrome

Who this might be right for
Alagille Syndrome
National Human Genome Research Institute (NHGRI) 225
Not applicableStudy completedNCT02131623
What this trial is testing

Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease

Who this might be right for
Alagille SyndromeProgressive Familial Intrahepatic Cholestasis
Mirum Pharmaceuticals, Inc. 23
Not applicableLooking for participantsNCT06506734
What this trial is testing

Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia

Who this might be right for
Dental Diseases
University Hospital, Toulouse 120
Not applicableLooking for participantsNCT07293897
What this trial is testing

A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)

Who this might be right for
Alagille Syndrome (ALGS)Progressive Familial Intrahepatic Cholestasis (PFIC)
Takeda 50
Not applicableApproved For MarketingNCT04530994
What this trial is testing

A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT04674761
What this trial is testing

Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Albireo 52
Not applicableLooking for participantsNCT07335523
What this trial is testing

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

Who this might be right for
Exocrine Pancreatic Insuficiency
Digestive Care, Inc. 30
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT04729751
What this trial is testing

Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).

Who this might be right for
Progressive Familial Intrahepatic CholestasisAlagille SyndromeCholestatic Liver Disease
Mirum Pharmaceuticals, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT02160782
What this trial is testing

Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 31
Not applicableLooking for participantsNCT06850038
What this trial is testing

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Who this might be right for
Alagille Syndrome
Ipsen 30
Not applicableLooking for participantsNCT07411716
What this trial is testing

Pediatric Evaluation and Registry for Liver Cholestasis in Canada

Who this might be right for
PFIC - Progressive Familial Intrahepatic CholestasisAlagille Syndrome (ALGS)Cholestasis, Intrahepatic
Children's Hospital of Eastern Ontario 220
Not applicableLooking for participantsNCT07585097
What this trial is testing

Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Who this might be right for
Alagille Syndrome
Ipsen 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05035030
What this trial is testing

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Albireo, an Ipsen Company 62
Early research (Phase 1)Study completedNCT02963077
What this trial is testing

A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

Who this might be right for
Orphan Cholestatic Liver DiseasesPrimary Biliary CirrhosisProgressive Familial Intrahepatic Cholestasis+1 more
Albireo 94
Next Page